Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MGX 292

Next Previous
Drug Profile

MGX 292

Alternative Names: MGX-292; Recombinant BMP 9 - Centessa Pharmaceuticals

Latest Information Update: 28 Apr 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Cambridge
  • Developer Centessa Pharmaceuticals
  • Class Antihypertensives; Recombinant proteins
  • Mechanism of Action Growth differentiation factor 2 replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Pulmonary arterial hypertension

Most Recent Events

  • 28 Apr 2024 No recent reports of development identified for preclinical development in Pulmonary-arterial-hypertension in United Kingdom (Intraperitoneal, Injection)
  • 19 May 2023 Pharmacodynamics data from a preclinical trial in Pulmonary-arterial-hypertension presented at the 119th International Conference of the American Thoracic Society (ATS-2023)
  • 30 Mar 2022 MGX 292 is still in preclinical development for Pulmonary-arterial-hypertension in the United Kingdom

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top